Choosing between revision endoscopic sinus surgery (ESS) versus biologic therapy for recurrent chronic rhinosinusitis with nasal polyposis (CRSwNP) is a complex, multifaceted decision that involves not only clinical and financial factors but also patient preferences. Currently, there are no quantitative studies investigating patient preferences for CRSwNP treatment options. Increased awareness of patient-centered approaches to treatment warrant further investigation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4193/Rhin24.475 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!